224 related articles for article (PubMed ID: 19473988)
21. GSK-3β/CREB axis mediates IGF-1-induced ECM/adhesion molecule expression, cell cycle progression and monolayer permeability in retinal capillary endothelial cells: Implications for diabetic retinopathy.
Devi TS; Singh LP; Hosoya K; Terasaki T
Biochim Biophys Acta; 2011 Sep; 1812(9):1080-8. PubMed ID: 21549192
[TBL] [Abstract][Full Text] [Related]
22. Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer's disease.
Shi H; Koronyo Y; Fuchs DT; Sheyn J; Wawrowsky K; Lahiri S; Black KL; Koronyo-Hamaoui M
Acta Neuropathol Commun; 2020 Nov; 8(1):202. PubMed ID: 33228786
[TBL] [Abstract][Full Text] [Related]
23. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor ligand-related molecule 1A maintains blood-retinal barrier via modulating SHP-1-Src-VE-cadherin signaling in diabetic retinopathy.
Li J; Xie R; Jiang F; Li Y; Zhu Y; Liu Z; Liao M; Liu Y; Meng X; Chen S; Yu J; Du M; Wang X; Chen Y; Yan H
FASEB J; 2021 Nov; 35(11):e22008. PubMed ID: 34679191
[TBL] [Abstract][Full Text] [Related]
25. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
26. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
[TBL] [Abstract][Full Text] [Related]
27. Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells
Zhang T; Ouyang H; Mei X; Lu B; Yu Z; Chen K; Wang Z; Ji L
FASEB J; 2019 Nov; 33(11):11776-11790. PubMed ID: 31365278
[TBL] [Abstract][Full Text] [Related]
28. N-Methyl-D-aspartate receptor activation, novel mechanism of homocysteine-induced blood-retinal barrier dysfunction.
Tawfik A; Mohamed R; Kira D; Alhusban S; Al-Shabrawey M
J Mol Med (Berl); 2021 Jan; 99(1):119-130. PubMed ID: 33159240
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
30. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
Deissler HL; Deissler H; Lang GK; Lang GE
Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
[TBL] [Abstract][Full Text] [Related]
31. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
[TBL] [Abstract][Full Text] [Related]
32. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules.
Xu H; Forrester JV; Liversidge J; Crane IJ
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):226-34. PubMed ID: 12506079
[TBL] [Abstract][Full Text] [Related]
33. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
34. Intravenously administered anti-recoverin antibody alone does not pass through the blood-retinal barrier.
Kim JH; Kim JH; Kim DH; Park WY; Kim KW; Yu YS
Korean J Ophthalmol; 2011 Jun; 25(3):189-95. PubMed ID: 21655045
[TBL] [Abstract][Full Text] [Related]
35. Synergistic interactions of PlGF and VEGF contribute to blood-retinal barrier breakdown through canonical NFκB activation.
Lennikov A; Mukwaya A; Fan L; Saddala MS; De Falco S; Huang H
Exp Cell Res; 2020 Dec; 397(2):112347. PubMed ID: 33130176
[TBL] [Abstract][Full Text] [Related]
36. Ferritin But Not Iron Increases in Retina Upon Systemic Iron Overload in Diabetic and Iron-Dextran Injected Mice.
Bonet A; Pampalona J; Jose-Cunilleras E; Nacher V; Ruberte J
Invest Ophthalmol Vis Sci; 2023 Mar; 64(3):22. PubMed ID: 36912597
[TBL] [Abstract][Full Text] [Related]
37. Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction.
Titchenell PM; Lin CM; Keil JM; Sundstrom JM; Smith CD; Antonetti DA
Biochem J; 2012 Sep; 446(3):455-67. PubMed ID: 22721706
[TBL] [Abstract][Full Text] [Related]
38. Conditional Müller Cell Ablation Leads to Retinal Iron Accumulation.
Baumann B; Sterling J; Song Y; Song D; Fruttiger M; Gillies M; Shen W; Dunaief JL
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4223-4234. PubMed ID: 28846772
[TBL] [Abstract][Full Text] [Related]
39. C1q/TNF-related protein-9 attenuates retinal inflammation and protects blood-retinal barrier in db/db mice.
Li W; Ma N; Liu MX; Ye BJ; Li YJ; Hu HY; Tang YH
Eur J Pharmacol; 2019 Jun; 853():289-298. PubMed ID: 30978318
[TBL] [Abstract][Full Text] [Related]
40. Diosmin alleviates retinal edema by protecting the blood-retinal barrier and reducing retinal vascular permeability during ischemia/reperfusion injury.
Tong N; Zhang Z; Zhang W; Qiu Y; Gong Y; Yin L; Qiu Q; Wu X
PLoS One; 2013; 8(4):e61794. PubMed ID: 23637907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
